Presynaptic opiate receptor-mediated inhibition of endogenous norepinephrine and dopamine-beta-hydroxylase release in the cat spleen, independent of the presynaptic alpha adrenoceptors.
D000818:Animals; D002415:Cats; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D004744:Enkephalin, Methionine / Q000494:pharmacology; D005089:Exocytosis / Q000187:drug effects; D005260:Female; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology*; D013154:Spleen / Q000294:innervation / Q000378:metabolism*; D013569:Synapses
D011942:Receptors, Adrenergic, alpha; D011957:Receptors, Opioid; D009270:Naloxone; D004744:Enkephalin, Methionine; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine; D010646:Phentolamine